LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin
· Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data
CAMBRIDGE, Massachusetts, Oct. 16, 2017 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc., a gene-therapy company with a mission to develop cures for early-onset life-threatening diseases, announced today that its company co-founder, Dr. Adi Barzel, will present new data from its genome-editing platform during the 25th Annual European Society of Gene & Cell Therapy (ESGCT) Congress in two presentations this Wednesday in Berlin, Germany. The ESGCT will be held from October 17-20, 2017, at the bcc Berlin.
Dr. Barzel will present data in multiple animal models of disease demonstrating the extended therapeutic potential of LogicBio's proprietary GeneRide(TM) platform technology. The GeneRide technology harnesses the natural power of homologous recombination to enable precise, site-specific in vivo genome editing to deliver therapeutic genetic material without the use of vector-borne promoters or nucleases.
"We are very excited to present proof-of-concept efficacy data in models of multiple genetic diseases and to demonstrate the breadth and the versatility of our GeneRideTM technology," said LogicBio President and CEO Fred Chereau. "We also feel fortunate developing our platform technology with world-renowned academic collaborators, enabling us to advance development candidates for early onset life-threatening diseases rapidly - from the benchtop into the clinic."
Due to the genomic editing feature, LogicBio's GeneRideTM technology has shown in preclinical studies that it can provide stable therapeutic levels of life-saving proteins after a single injection. It overcomes a major challenge of the conventional gene therapy in pediatric indications - dilution of therapeutic benefit due to the proliferation of cells in the growing tissue of a child. Thus, the GeneRide technology is uniquely suitable to treat many rare, early-onset and severe genetic diseases.
LogicBio presentations at the ESGCT Congress are as follows:
Title: GeneRide(TM): Therapeutic in vivo gene targeting without nucleases
Session: Gene Editing I
When: October 18, 2017, 2:40 p.m. CEST
Title: GeneRide(TM): Therapeutic in vivo gene targeting without nucleases
When: October 18, 2017, 6:50 p.m. CEST
Abstract Number: P129
A co-founder of LogicBio, Dr. Barzel is the president elect of the Israeli Society of Gene and Cell Therapy and a senior lecturer (associate professor) at the Department of Biochemistry at Tel Aviv University. Dr. Barzel has a research background in homologous recombination and gene targeting. He is a Summa cum Laude graduate of the Adi Lautman interdisciplinary program for outstanding students, and has earned his PhD in genetics from the laboratory of Professor Martin Kupiec at Tel Aviv University. Previously, Major Adi Barzel was a company commander in an armor brigade and in the officer's academy of the Israeli Defense Forces. He invented the GeneRide technology during his time as a postdoctoral fellow at the Kay Lab at Stanford Medicine, Stanford University. He has co-authored scientific papers in high-impact journals describing the GeneRide technology and its applications.
A preclinical-stage company with a mission to develop cures for life-threatening diseases, LogicBio combines the best of gene therapy and genome-editing technology. Founded by gene-therapy pioneers from leading academic institutions including Stanford University, Tel Aviv University, and Children's Medical Research Institute in Sydney - the company's core platform includes its proprietary GeneRide technology and synthetic gene-therapy vectors derived from naturally occurring human adeno-associated viruses. LogicBio designed its approach to harness the natural power of homologous recombination - enabling precise, site-specific transfer of the genetic material without the use of vector-borne promoters or nucleases, which could be associated with unwanted side effects. The goal: provide patients with a functional version of a faulty, disease-causing gene to deliver a cure. LogicBio is advancing programs for rare, life-threatening pediatric genetic diseases - focusing first on inborn errors of metabolism, where there are few, if any, treatment options. A number of the company's discoveries have been featured in leading science publications and conferences. A private company, LogicBio is based in Cambridge, Massachusetts, with a research group in Tel Aviv.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/21431f6d-93d7-4c5f-a5d1-1a51641c6b2f
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/81511cac-ee28-4f0e-add0-dcceb0ea0a5c
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/95980a56-cec5-4e55-850b-a5f2a1713159
LogicBio Therapeutics, Inc.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LogicBio Therapeutics, Inc. via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
LeoVegas fortsätter att investera för framtiden med lansering av ny front-end plattform23.5.2018 15:54 | Pressmeddelande
Front-end plattformen är det som kunderna möts av på LeoVegas.com. Tekniken skapar nya och förbättrade möjligheter för LeoVegas att fortsätta erbjuda den bästa, snabbaste och mest innovativa spelupplevelsen på mobilen. "Vi fortsätter att investera i den senaste tekniken för att ständigt utveckla kundupplevelsen och skapa förutsättningar för stark tillväxt. Tillsammans med vår back-end plattform, Rhino, behåller vi vårt teknikförsprång i branschen och fortsätter att vara det ledande GameTech bolaget genom att arbeta med teknik i världsklass", säger Gustaf Hagman, CEO LeoVegas. Fördelarna med den nya plattformen är många och visar på att LeoVegas är det ledande GameTech bolaget: Snabbare laddning och därmed en bättre upplevelse för kunden. Möjligheter till ett förbättrat SEO-arbete ökar markant. Värdet av förbättrad SEO är att kunderna kommer hitta direkt till Leovegas.com via sökmotorer istället för att gå via tredje part, så kallade affiliate-sajter. LeoVegas har en förväntan om att ök
LeoVegas continues to invest for the future with the launch of a new front-end platform23.5.2018 15:54 | Pressmeddelande
The front-end platform is what the customers meet when entering LeoVegas.com. The technology creates new and improved opportunities for LeoVegas to offer the best, fastest and most innovative mobile gaming experience. "We are investing further in state-of-the-art technology in order to continuously develop the customer experience and to create conditions for strong growth. Together with our back-end platform, Rhino, we are maintaining our technological lead in the industry and continue to be the leading GameTech company by working with world class technology," comments Gustaf Hagman, Group CEO of LeoVegas. The platform offers wide range of benefits which demonstrate LeoVegas' position as the leading GameTech company: The platform enables faster loading times and thus a better customer experience. The platform opens significantly greater opportunities for improved Search Engine Optimisation (SEO). The value of improved SEO is that customers will be directed straight to Leovegas.com via
GaN Systems to Showcase Innovative GaN Power Technologies and Customer Solutions at PCIM Europe 201823.5.2018 15:00 | Pressmeddelande
Record-setting GaN transistors and an array of new products, design tools, and reference designs that make it easier to develop ground-breaking power systems will be displayed OTTAWA, May 23, 2018 (GLOBE NEWSWIRE) -- GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced that it will be exhibiting the company's new products and design tools and presenting customer demonstrations at PCIM Europe 2018 (Power Conversion and Intelligent Motion), Booth 511 in Hall 9 (9-511) from June 5-6, 2018 in Nuremberg, Germany. At PCIM Europe, one of the leading exhibitions for power electronics and its applications, attendees to the GaN Systems booth will learn about new products, the numerous IC companies that have collaborated with GaN Systems, and a vast array of customer implementations spanning the consumer, data center, industrial, and automotive market segments. Also, GaN Systems' subject matter experts will be speaking at four sessions over the course of t
Addiko Bank Implements Digital Banking Solutions on Appian23.5.2018 13:30 | Pressmeddelande
Digital Lending and Trade Finance applications cut customer wait times in half RESTON, Va., BELGRADE, Serbia and LJUBLJANA, Slovenia, May 23, 2018 (GLOBE NEWSWIRE) -- Appian (Nasdaq:APPN) and Addiko Bank, an international financial group headquartered in Vienna, Austria, today announced that the bank has deployed two new digital banking applications on Appian's low code application platform. The applications cover Lending and Trade Finance processes across Addiko's Corporate and Small Medium Enterprise (SME) customers. The applications have reduced customer wait times by as much as 50% by cutting "time to yes" for simple loans down from one week to just three days. Addiko Bank is the only financial group primarily focused on markets in the South Eastern Europe region (SEE), servicing more than 1 million customers. With these Appian deployments, Addiko Bank is the first bank within the SEE region to provide such a digital banking platform to customers in Slovenia and Serbia. Addiko is a
GMO Internet Group Offers GMO miner, The World's First Mining Machine Equipped with Mining Chips Using a Cutting-Edge 7 nm Process Technology: information session on Wednesday, June 623.5.2018 13:03 | Pressmeddelande
TOKYO, May 23, 2018 (GLOBE NEWSWIRE) -- Tokyo, Japan - May 23, 2018 - GMO Internet Group (https://www.gmo.jp/en/ ) will launch GMO miner (product name: GMO miner B2), which is our own high-performance computer for mining (mining machine), on Wednesday, June 6, 2018. We will mass-produce the world's first mining machine equipped with a cutting-edge 7 nm* process based semiconductor chip (7 nm mining chip; "GMO 72b"), which will be shipped at the end of October 2018. As a result, an information session for potential customers considering the purchase of GMO miner will be held on Wednesday, June 6 in Shibuya, Tokyo, and we will explain the details of GMO miner, such as price and performance. *nm: nanometer. 1/1 billion meters. 1/1 million millimeters. Selling "GMO miner" Cryptocurrency mining requires high-performance mining machines enabling highly sophisticated and intensive computation. Accordingly, GMO Internet Group has been working on research and development of a cutting-edge 7 nm
SolarWinds Extends Network Management Software Leadership with Deeper Visibility and Smarter Scalability23.5.2018 12:30 | Pressmeddelande
Software now simplifies management of complex networks with Network Insight for Cisco Nexus and intelligent mapping, supporting environments four times larger than previous generation AUSTIN, Texas, May 23, 2018 (GLOBE NEWSWIRE) -- SolarWinds, the worldwide leader in network management software, today announced a wave of updates to its network management product portfolio, which can now support networks up to four times larger than the previous generation. This significant gain makes it easy to consolidate monitoring solutions to a single provider enterprise-wise, and gives IT professionals far greater flexibility to scale up and support larger data center networks as workloads increase, or scale out to address complex distributed networks. SolarWinds says the broad refresh of its network management portfolio strengthens its IDC®-validated network management leadership position.1 Updated versions of Network Performance Monitor (NPM), Network Configuration Manager (NCM), IP Address Mana
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum